BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 16026602)

  • 1. Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).
    Hong H; Dragan Y; Epstein J; Teitel C; Chen B; Xie Q; Fang H; Shi L; Perkins R; Tong W
    BMC Bioinformatics; 2005 Jul; 6 Suppl 2(Suppl 2):S5. PubMed ID: 16026602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated multi-level quality control for proteomic profiling studies using mass spectrometry.
    Cairns DA; Perkins DN; Stanley AJ; Thompson D; Barrett JH; Selby PJ; Banks RE
    BMC Bioinformatics; 2008 Dec; 9():519. PubMed ID: 19055809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in protein profiles of the isolates of Entamoeba histolytica and E. dispar by surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF MS) ProteinChip assays.
    Makioka A; Kumagai M; Kobayashi S; Takeuchi T
    Parasitol Res; 2007 Dec; 102(1):103-10. PubMed ID: 17846790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
    de Seny D; Fillet M; Meuwis MA; Geurts P; Lutteri L; Ribbens C; Bours V; Wehenkel L; Piette J; Malaise M; Merville MP
    Arthritis Rheum; 2005 Dec; 52(12):3801-12. PubMed ID: 16320331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative quality-assessment techniques to compare fractionation and depletion methods in SELDI-TOF mass spectrometry experiments.
    Harezlak J; Wang M; Christiani D; Lin X
    Bioinformatics; 2007 Sep; 23(18):2441-8. PubMed ID: 17626063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip technology in proteomics research.
    Seibert V; Wiesner A; Buschmann T; Meuer J
    Pathol Res Pract; 2004; 200(2):83-94. PubMed ID: 15237917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) to study protein expression in a rat model of cocaine withdrawal.
    Geng T; Seitz PK; Thomas ML; Xu B; Soman KV; Kurosky A; Luxon BA; Cunningham KA
    J Neurosci Methods; 2006 Nov; 158(1):1-12. PubMed ID: 16766040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients.
    Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
    J Zhejiang Univ Sci B; 2006 Mar; 7(3):235-40. PubMed ID: 16502512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.
    Brozkova K; Budinska E; Bouchal P; Hernychova L; Knoflickova D; Valik D; Vyzula R; Vojtesek B; Nenutil R
    Breast Cancer Res; 2008; 10(3):R48. PubMed ID: 18510725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
    Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
    Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry: serum protein profiling in seminoma patients.
    Strenziok R; Hinz S; Wolf C; Conrad T; Krause H; Miller K; Schrader M
    World J Urol; 2010 Apr; 28(2):193-7. PubMed ID: 19529944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.
    Semmes OJ; Feng Z; Adam BL; Banez LL; Bigbee WL; Campos D; Cazares LH; Chan DW; Grizzle WE; Izbicka E; Kagan J; Malik G; McLerran D; Moul JW; Partin A; Prasanna P; Rosenzweig J; Sokoll LJ; Srivastava S; Srivastava S; Thompson I; Welsh MJ; White N; Winget M; Yasui Y; Zhang Z; Zhu L
    Clin Chem; 2005 Jan; 51(1):102-12. PubMed ID: 15613711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein profiling as a diagnostic tool in clinical chemistry: a review.
    Bons JA; Wodzig WK; van Dieijen-Visser MP
    Clin Chem Lab Med; 2005; 43(12):1281-90. PubMed ID: 16309363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations in quantitation of the biomarker CCL18 in Gaucher disease blood samples by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    van Breemen MJ; Bleijlevens B; de Koster CG; Aerts JM
    Biochim Biophys Acta; 2006 Oct; 1764(10):1626-32. PubMed ID: 17010683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.